Literature DB >> 12851685

HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia.

Giovanna Maria Pierantoni1, Basilia Santulli, Irene Caliendo, Francesca Pentimalli, Gennaro Chiappetta, Nicola Zanesi, Massimo Santoro, Florencia Bulrich, Alfredo Fusco.   

Abstract

We report the first case of acute lymphoblastic leukemia associated with a t(9;12)(p22;q14) translocation within the HMGA2 locus. The breakpoint lies in the 5' region. Fluorescence in situ hybridization with a BAC clone covering the 5' region produced three signals versus two signals with a BAC clone covering the 3' region including intron 3 of HMGA2, which harbors most of the breakpoints described in benign mesenchymal tumors. HMGA2 locus rearrangement was associated with overexpression of an HMGA2 mRNA that lacked a carboxy-terminal tail. These results suggest that the HMGA2 gene rearrangement may contribute to the malignancy in leukemias harboring a 12q translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851685

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas.

Authors:  Azra H Ligon; Steven D P Moore; Melissa A Parisi; Matthew E Mealiffe; David J Harris; Heather L Ferguson; Bradley J Quade; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2004-12-10       Impact factor: 11.025

Review 2.  Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature.

Authors:  Neil J Rawlinson; William W West; Marilu Nelson; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2008-03

3.  TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.

Authors:  Irene Riz; Teresa S Hawley; Truong V Luu; Norman H Lee; Robert G Hawley
Journal:  Mol Cancer       Date:  2010-07-09       Impact factor: 27.401

Review 4.  Critical role of the high mobility group A proteins in hematological malignancies.

Authors:  Marco De Martino; Francesco Esposito; Alfredo Fusco
Journal:  Hematol Oncol       Date:  2021-10-12       Impact factor: 4.850

5.  HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.

Authors:  Shuo Yang; Yueli Gu; Genjie Wang; Qingzhu Hu; Shuxia Chen; Yong Wang; Mingfeng Zhao
Journal:  Int J Mol Med       Date:  2019-06-05       Impact factor: 4.101

6.  3' UTR-truncated HMGA2 overexpression induces non-malignant in vivo expansion of hematopoietic stem cells in non-human primates.

Authors:  Melissa A Bonner; Antonio Morales-Hernández; Sheng Zhou; Zhijun Ma; Jose Condori; Yong-Dong Wang; Soghra Fatima; Lance E Palmer; Laura J Janke; Stephanie Fowler; Brian P Sorrentino; Shannon McKinney-Freeman
Journal:  Mol Ther Methods Clin Dev       Date:  2021-05-01       Impact factor: 6.698

7.  Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia.

Authors:  A Efanov; N Zanesi; V Coppola; G Nuovo; B Bolon; D Wernicle-Jameson; A Lagana; A Hansjuerg; F Pichiorri; C M Croce
Journal:  Blood Cancer J       Date:  2014-07-11       Impact factor: 11.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.